Sign inGet started

PYXS

Pyxis Oncology, Inc.CIK 1782223 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
1 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20

AI insights for PYXS PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for PYXS
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$12026-10-01 buys — 2026-10-01 sales —10-01
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
GordonMD Global Investments LP10% Owner3—$02026-10-01
Civik ThomasInterim CEO, Director11$200.0K$02026-09-04
Dupont JakobDirector12$0$107.1K2026-08-20
Palani SanthoshDirector4$0$02026-03-24
Wadhane JitendraSVP, Chief Accounting Officer14$17.9K$02026-03-24
Cline Darren SDirector7$93.9K$02026-03-24
HUMPHREY RACHELDirector8$0$15.9K2026-03-24
Metzger Michael ADirector3$0$02026-03-24
Lewis-Hall Freda CDirector6$0$02026-03-24
FLAVIN JOHN LDirector8$0$02026-03-24
Yanchik Connealy PamelaChief Financial Officer20$230.0K$02025-03-31
Sullivan LaraPresident and CEO19$0$81.4K2025-03-31
Kobayashi KenChief Medical Officer2$0$02023-12-29
Feingold JayChief Medical Officer10$0$02023-03-24
PFIZER INC10% Owner2$10.00M$02023-03-17
Chin MarkOther6$5.00M$5.32M2022-04-21
Bayer World Investments B.V.Other3$0$02021-10-13
Cormorant Asset Management, LPOther3$7.20M$02021-10-13
Herbst RonaldChief Scientific Officer1$0$02021-10-07
Shah RituChief Operating Officer1$0$02021-10-07

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
GordonMD Global Investments LP10% Owner P Buy deriv2026-10-012026-10-027,546,766— —7,546,766SEC↗
GordonMD Global Investments LP10% Owner P Buy2026-10-012026-10-025,517,000— —15,541,909SEC↗
GordonMD Global Investments LP10% Owner P Buy deriv2026-10-012026-10-097,172,000— —7,172,000SEC↗
Civik ThomasCEO & Chairman of the Board A Award deriv2026-09-042026-09-082,503,050— $02,503,050SEC↗
Civik ThomasCEO & Chairman of the Board, A Award deriv2026-09-042026-09-082,503,050— $02,503,050SEC↗
Dupont JakobDirector A Award deriv2026-08-202026-08-2046,000— $046,000SEC↗
Dupont JakobDirector A Award deriv2026-08-202026-08-2046,000— $046,000SEC↗
Civik ThomasInterim CEO A Award deriv2026-08-122026-08-14250,956— $0941,087SEC↗
Civik ThomasInterim CEO, Director A Award deriv2026-08-122026-08-14250,956— $0941,087SEC↗
Dupont JakobDirector M Exercise deriv2026-06-302026-07-0235,000— $0357,461SEC↗
Dupont JakobDirector M Exercise2026-06-302026-07-0235,000$1.60 $56.0K73,741SEC↗
Dupont JakobDirector S Sale2026-06-302026-07-0235,000$3.06 $107.1K38,741SEC↗
Palani SanthoshDirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
HUMPHREY RACHELDirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
Cline Darren SDirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
Lewis-Hall Freda CDirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
Metzger Michael ADirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
FLAVIN JOHN LDirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
Wadhane JitendraPrin Fin & Acct Officer A Award deriv2026-03-242026-03-25262,635— $0262,635SEC↗
Dupont JakobDirector A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
Wadhane JitendraPrin Fin & Acct Officer A Award2026-03-242026-03-25109,461— $0512,882SEC↗
Civik ThomasInterim CEO A Award deriv2026-02-032026-02-05690,131— $0690,131SEC↗
HUMPHREY RACHELDirector S Sale2025-04-212026-03-2513,896$1.03 $14.3K81,309SEC↗
HUMPHREY RACHELDirector S Sale2025-04-172026-03-25200$0.97 $19495,205SEC↗
HUMPHREY RACHELDirector S Sale2025-04-142026-03-251,400$0.97 $1.4K95,405SEC↗
FLAVIN JOHN LDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Connealy Pamela AnnCFO & COO A Award deriv2025-03-312025-04-02414,163$0.98 $405.9K414,163SEC↗
Civik ThomasDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Palani SanthoshDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Dupont JakobDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Cline Darren SDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Lewis-Hall Freda CDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
HUMPHREY RACHELDirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Wadhane JitendraSVP, Chief Accounting Office A Award deriv2025-03-312025-04-02263,782$0.98 $258.5K263,782SEC↗
Metzger Michael ADirector A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
Sullivan LaraPresident ,CEO & CMO A Award deriv2025-03-312025-04-02918,308$0.98 $899.9K918,308SEC↗
Wadhane JitendraSVP, Chief Accounting Office A Award deriv2024-12-232024-12-23150,000— $0150,000SEC↗
Connealy Pamela AnnCFO & COO A Award deriv2024-12-232024-12-23310,000— $0310,000SEC↗
Sullivan LaraChief Executive Officer A Award deriv2024-12-232024-12-231,135,000— $01,135,000SEC↗
Connealy Pamela AnnCFO & COO P Buy2024-11-262024-11-2783,400$1.96 $163.5K1,199,143SEC↗
Connealy Pamela AnnCFO & COO P Buy2024-11-262024-11-275,450$2.00 $10.9K1,115,743SEC↗
Metzger Michael ADirector A Award deriv2024-06-102024-06-1070,683— $070,683SEC↗
Palani SanthoshDirector A Award2024-06-072024-06-076,000— $06,000SEC↗
Civik ThomasDirector A Award deriv2024-03-262024-03-2844,024$3.83 $168.6K44,024SEC↗
Sullivan LaraChief Executive Officer A Award deriv2024-03-262024-03-281,071,242$3.83 $4.10M1,071,242SEC↗
Wadhane JitendraSVP, Chief Accounting Office A Award2024-03-262024-03-28131,484— $0398,421SEC↗
HUMPHREY RACHELDirector A Award2024-03-262024-03-2838,741— $096,805SEC↗
Dupont JakobDirector A Award2024-03-262024-03-2838,741— $038,741SEC↗
Lewis-Hall Freda CDirector A Award2024-03-262024-03-2835,219— $0241,405SEC↗
FLAVIN JOHN LDirector A Award2024-03-262024-03-2835,219— $0413,015SEC↗
Cline Darren SDirector A Award2024-03-262024-03-2835,219— $0251,405SEC↗
Connealy Pamela AnnCFO & COO A Award2024-03-262024-03-28328,710— $01,110,293SEC↗
Palani SanthoshDirector A Award deriv2024-03-122024-03-1369,760— $069,760SEC↗
Kobayashi KenChief Medical Officer A Award deriv2023-12-292023-12-29110,878— $0110,878SEC↗
Kobayashi KenChief Medical Officer A Award deriv2023-12-292023-12-29443,514— $0443,514SEC↗
Connealy Pamela AnnCFO and COO F Tax w/h2023-11-292023-11-3036,949$1.40 $51.7K781,583SEC↗
Wadhane JitendraChief Accounting Officer A Award2023-11-152023-11-1740,000— $0266,937SEC↗
Connealy Pamela AnnCFO and COO P Buy2023-09-282023-09-288,000$1.87 $15.0K818,532SEC↗
Connealy Pamela AnnCFO and COO P Buy2023-09-272023-09-276,426$1.85 $11.9K810,532SEC↗
Wadhane JitendraChief Accounting Officer P Buy2023-09-272023-09-272,500$1.87 $4.7K226,937SEC↗
Connealy Pamela AnnCFO and COO P Buy2023-09-252023-09-2512,000$1.67 $20.0K804,106SEC↗
Wadhane JitendraChief Accounting Officer P Buy2023-09-252023-09-255,000$1.77 $8.8K224,437SEC↗
Dupont JakobDirector A Award deriv2023-09-222023-09-26392,461— $0392,461SEC↗
Connealy Pamela AnnCFO and COO P Buy2023-09-222023-09-225,000$1.74 $8.7K792,106SEC↗
Wadhane JitendraChief Accounting Officer P Buy2023-09-222023-09-222,500$1.74 $4.3K219,437SEC↗
Sullivan LaraPresident and CEO S Sale2023-09-182023-09-188,541$2.10 $17.9K2,403,882SEC↗
Sullivan LaraPresident and CEO S Sale2023-09-142023-09-18100$2.25 $2252,412,423SEC↗
Sullivan LaraPresident and CEO F Tax w/h2023-09-132023-09-13184,742$2.13 $393.5K2,412,523SEC↗
Sullivan LaraPresident and CEO S Sale2023-09-132023-09-133,000$2.27 $6.8K2,597,265SEC↗
Sullivan LaraPresident and CEO S Sale2023-09-122023-09-134,917$2.25 $11.1K2,600,265SEC↗
Sullivan LaraPresident and CEO S Sale2023-09-112023-09-1320,000$2.27 $45.4K2,605,182SEC↗
Sullivan LaraPresident and CEO A Award2023-09-072023-09-08469,483— $02,625,182SEC↗
Wadhane JitendraChief Accounting Officer A Award2023-09-072023-09-0893,896— $0211,937SEC↗
Connealy Pamela AnnCFO and COO A Award2023-09-072023-09-08187,793— $0782,106SEC↗
Dupont JakobDirector A Award deriv2023-08-232023-08-2517,250— $017,250SEC↗
Dupont JakobDirector A Award deriv2023-08-232023-08-253,534— $03,534SEC↗
Dupont JakobDirector A Award deriv2023-08-232023-08-255,879— $05,879SEC↗
Wadhane JitendraChief Accounting Officer A Award deriv2023-03-242023-03-28157,257— $0157,257SEC↗
Wadhane JitendraChief Accounting Officer D To issuer deriv2023-03-242023-03-28157,257— $00SEC↗
Feingold JayChief Medical Officer D To issuer deriv2023-03-242023-03-28157,257— $00SEC↗
Feingold JayChief Medical Officer D To issuer deriv2023-03-242023-03-2817,517— $00SEC↗
Feingold JayChief Medical Officer A Award deriv2023-03-242023-03-28157,257— $0157,257SEC↗
Feingold JayChief Medical Officer A Award deriv2023-03-242023-03-2817,517— $017,517SEC↗
Yanchik Connealy PamelaCFO and COO D To issuer deriv2023-03-242023-03-2810,304— $00SEC↗
Yanchik Connealy PamelaCFO and COO D To issuer deriv2023-03-242023-03-28322,265— $00SEC↗
Yanchik Connealy PamelaCFO and COO A Award deriv2023-03-242023-03-28322,265— $0322,265SEC↗
Yanchik Connealy PamelaCFO and COO A Award deriv2023-03-242023-03-2810,304— $010,304SEC↗
Sullivan LaraPresident and CEO A Award deriv2023-03-242023-03-2861,825— $061,825SEC↗
Sullivan LaraPresident and CEO A Award deriv2023-03-242023-03-28990,461— $0990,461SEC↗
Sullivan LaraPresident and CEO D To issuer deriv2023-03-242023-03-2861,825— $00SEC↗
Sullivan LaraPresident and CEO D To issuer deriv2023-03-242023-03-28990,461— $00SEC↗
Civik ThomasDirector A Award2023-03-242023-03-28139,355— $0206,186SEC↗
Cline Darren SDirector A Award2023-03-242023-03-28139,355— $0216,186SEC↗
FLAVIN JOHN LDirector A Award2023-03-242023-03-28139,355— $0377,796SEC↗
HUMPHREY RACHELDirector A Award2023-03-242023-03-2858,064— $058,064SEC↗
Lewis-Hall Freda CDirector A Award2023-03-242023-03-28139,355— $0206,186SEC↗
Wadhane JitendraChief Accounting Officer A Award2023-03-242023-03-2845,000— $088,648SEC↗
Wadhane JitendraChief Accounting Officer A Award2023-03-242023-03-2829,393— $0118,041SEC↗
Feingold JayChief Medical Officer A Award2023-03-242023-03-28209,803— $0730,345SEC↗
Yanchik Connealy PamelaCFO and COO A Award2023-03-242023-03-28209,803— $0594,313SEC↗
Sullivan LaraPresident and CEO A Award2023-03-242023-03-28703,379— $02,155,699SEC↗
PFIZER INC10% Owner P Buy2023-03-172023-03-211,811,594$2.76 $5.00M5,952,263SEC↗
PFIZER INC10% Owner P Buy2023-03-172023-03-231,811,594$2.76 $5.00M5,952,263SEC↗
Yanchik Connealy PamelaChief Financial Officer A Award2023-01-032023-01-0343,493— $0384,510SEC↗
Feingold JayChief Medical Officer A Award2023-01-032023-01-0353,931— $0520,542SEC↗
Sullivan LaraChief Executive Officer A Award2023-01-032023-01-0395,684— $01,452,320SEC↗
HUMPHREY RACHELDirector A Award deriv2022-08-112022-08-15236,220— $0236,220SEC↗
Chin MarkOther S Sale2022-04-212022-04-251,745,761$3.05 $5.32M0SEC↗
Sullivan LaraChief Executive Officer A Award2022-04-142022-04-15315,273— $01,356,636SEC↗
Feingold JayChief Medical Officer A Award2022-04-142022-04-15115,931— $0466,611SEC↗
Yanchik Connealy PamelaChief Financial Officer A Award2022-04-142022-04-1593,493— $0341,017SEC↗
Lewis-Hall Freda CDirector A Award2022-03-312022-04-0466,831— $066,831SEC↗
Cline Darren SDirector A Award2022-03-312022-04-0466,831— $076,831SEC↗
Yanchik Connealy PamelaChief Financial Officer A Award2022-03-312022-04-04247,524— $0247,524SEC↗
Chin MarkDirector A Award2022-03-312022-04-0466,831— $066,831SEC↗
Feingold JayChief Medical Officer A Award2022-03-312022-04-04306,930— $0350,680SEC↗
Civik ThomasDirector A Award2022-03-312022-04-0466,831— $066,831SEC↗
FLAVIN JOHN LDirector A Award2022-03-312022-04-0466,831— $0238,441SEC↗
Sullivan LaraChief Executive Officer A Award2022-03-312022-04-04742,574— $01,041,363SEC↗
Cline Darren SDirector P Buy2021-12-082021-12-0910,000$9.39 $93.9K10,000SEC↗
Yanchik Connealy PamelaChief Financial Officer A Award deriv2021-12-062021-12-0752,944— $052,944SEC↗
Civik ThomasDirector P Buy2021-11-182021-11-1915,700$12.74 $200.0K15,700SEC↗
Cormorant Asset Management, LPOther C Conversion deriv2021-10-132021-10-15668,854— $00SEC↗
Bayer World Investments B.V.Other C Conversion deriv2021-10-132021-10-156,076,072— $00SEC↗
Bayer World Investments B.V.Other C Conversion deriv2021-10-132021-10-1511,362,462— $00SEC↗
FLAVIN JOHN LDirector C Conversion deriv2021-10-132021-10-1515,190— $00SEC↗
Chin MarkDirector C Conversion deriv2021-10-132021-10-159,114,109— $00SEC↗
Cormorant Asset Management, LPOther C Conversion2021-10-132021-10-15668,854— $0668,854SEC↗
Cormorant Asset Management, LPOther P Buy2021-10-132021-10-15450,000$16.00 $7.20M1,118,854SEC↗
Bayer World Investments B.V.Other C Conversion2021-10-132021-10-152,742,338— $02,742,338SEC↗
FLAVIN JOHN LDirector C Conversion2021-10-132021-10-152,388— $0171,610SEC↗
Chin MarkDirector C Conversion2021-10-132021-10-151,433,261— $01,433,261SEC↗
Chin MarkDirector P Buy2021-10-132021-10-15312,500$16.00 $5.00M1,745,761SEC↗
Shah RituChief Operating Officer A Award deriv2021-10-072021-10-1231,344— $031,344SEC↗
Herbst RonaldChief Scientific Officer A Award deriv2021-10-072021-10-1228,252— $028,252SEC↗
Sullivan LaraChief Executive Officer A Award deriv2021-10-072021-10-12962,289— $0962,289SEC↗
Lewis-Hall Freda CDirector A Award deriv2021-10-072021-10-1242,191— $042,191SEC↗
Chin MarkDirector A Award deriv2021-10-072021-10-1242,191— $042,191SEC↗
Feingold JayChief Medical Officer A Award deriv2021-10-072021-10-12436,929— $0436,929SEC↗
Cline Darren SDirector A Award deriv2021-10-072021-10-1242,191— $042,191SEC↗
FLAVIN JOHN LDirector A Award deriv2021-10-072021-10-1242,191— $042,191SEC↗
Civik ThomasDirector A Award deriv2021-10-072021-10-1242,191— $042,191SEC↗
Feingold JayChief Medical Officer A Award2021-10-072021-10-1243,750— $043,750SEC↗